A tumor-derived metabolite primes the leptomeningeal pre-metastatic niche
Trending
- Weighing the Catabolic Effects of Lenvatinib/Everolimus vs SOC in ccRCC
- How Did KRAS Become an Actionable Target in Oncology?
- Tumor-derived annexin A1 drives lenvatinib resistance by regulating SOX2/STAT3/S100A6 feedback loop and M2 macrophage polarization in hepatocellular carcinoma
- How “Missing the Boat” Led Me Somewhere Better
- AI-Based Pan-TEAD Inhibitor Wins FDA Fast Track Designation in Mesothelioma
- Implementing GU Takeaways From the 2026 ASCO Into Clinical Practice
- Equitable Access to Cellular Therapy Requires More Than Certification
- HERC4 synergizes with USP16 to promote lung adenocarcinoma growth by augmenting protein translation via stabilizing RPS15

